Park, Jin-Woo
Chung, Hyewon
Kim, Jong-Min
Kim, Na Young
Hong, Sung Hee
Kim, Kyoung-Ah
Park, Ji-Young
Clinical trials referenced in this document:
Documents that mention this clinical trial
Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants
https://doi.org/10.1007/s40268-024-00460-y
Funding for this research was provided by:
Hanmi Pharmaceutical Co., Ltd
Article History
Accepted: 24 March 2024
First Online: 22 May 2024
Declarations
:
: This study was sponsored by Hanmi Pharmaceutical Co., Ltd., Seoul, Korea.
: Na Young Kim and Sung Hee Hong are employees of Hanmi Pharmaceutical Co., Ltd.
: The datasets and materials in the current study are available from the corresponding author upon reasonable request.
: The study protocol was approved (IRB no. 2018AN0310, clinicaltrial.gov; NCT04322266) by the Institutional Review Board of Anam Hospital, Korea University Medical Center (Seoul, Korea), and all procedures were conducted in accordance with the principles described in the Declaration of Helsinki and Good Clinical Practice guidelines.
: All patients provided written consent prior to study enrollment.
: Not applicable.
: Not applicable.
: H.C. and J-W.P. were responsible for acquisition of data, analysis and interpretation of data, and drafting the article; J-Y.P. provided the conception and design of the study, revised the article critically for important intellectual content, and gave final approval of the version; K-A.K. supplied the design of the study, analysis, and interpretation; and J-M.K., N.Y.K., and S.H.H were responsible for acquisition of data and analysis.